Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03576131
What this trial is testing

GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors

Who this might be right for
Colorectal CancerNon-small Cell Lung CancerTriple Negative Breast Cancer+4 more
Genmab 48
Not applicableLooking for participantsNCT06073431
What this trial is testing

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Who this might be right for
Advanced Colorectal CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Pancreatic Adenocarcinoma+6 more
University of Rochester 800
Testing effectiveness (Phase 2)Study completedNCT00416650
What this trial is testing

Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 16
Testing effectiveness (Phase 2)Ended earlyNCT00003491
What this trial is testing

Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer

Who this might be right for
Stage IV Lung Cancer
Burzynski Research Institute 17
Testing effectiveness (Phase 2)Ended earlyNCT02608268
What this trial is testing

Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignancies
Novartis Pharmaceuticals 252
Testing effectiveness (Phase 2)Active Not RecruitingNCT05286294
What this trial is testing

Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders

Who this might be right for
Melanoma Stage IVHead and Neck Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma+3 more
Oslo University Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT01871480
What this trial is testing

CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Kunming Medical University 50
Testing effectiveness (Phase 2)Study completedNCT01065441
What this trial is testing

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

Who this might be right for
Solid Tumors Stage II, Stage III and Stage IVBreast CancerColorectal Cancer+5 more
Michael Har-Noy 9
Testing effectiveness (Phase 2)Ended earlyNCT00528775
What this trial is testing

Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air Passages

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute 6
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Early research (Phase 1)Ended earlyNCT03621982
What this trial is testing

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Who this might be right for
Head and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more
ADC Therapeutics S.A. 78
Testing effectiveness (Phase 2)UnknownNCT02886897
What this trial is testing

Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors

Who this might be right for
Hepatocellular CarcinomaRenal Cell CarcinomaBladder Cancer+3 more
Sun Yat-sen University 50
Testing effectiveness (Phase 2)UnknownNCT00003562
What this trial is testing

Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Hope Cancer Institute, Inc. 38
Testing effectiveness (Phase 2)Study completedNCT01059188
What this trial is testing

Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
Swiss Cancer Institute 69
Early research (Phase 1)Looking for participantsNCT07458347
What this trial is testing

Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Who this might be right for
KRAS-mutant Non-small Cell Lung Cancer (NSCLC)KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC)KRAS-mutant Colorectal Cancer (CRC)+1 more
Kestrel Therapeutics, Inc. 145
Not applicableStudy completedNCT02679443
What this trial is testing

Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy

Who this might be right for
Lung AdenocarcinomaNeutropeniaAnemia+2 more
Post Graduate Institute of Medical Education and Research, Chandigarh 161
Testing effectiveness (Phase 2)UnknownNCT01502202
What this trial is testing

Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers

Who this might be right for
Non Small Cell Lung CancerAdenocarcinoma
National Cancer Center, Korea 162
Testing effectiveness (Phase 2)Study completedNCT00103207
What this trial is testing

Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group 72
Testing effectiveness (Phase 2)Study completedNCT00534001
What this trial is testing

Bupropion in Helping Adults Stop Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Roswell Park Cancer Institute 95
Testing effectiveness (Phase 2)Active Not RecruitingNCT04280081
What this trial is testing

Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation

Who this might be right for
Solid TumorMedullary Thyroid Cancer
Eli Lilly and Company 77
Next Page